This inventor holds 3 USPTO granted patents and 1 EPO patent. Top assignees: Hitachi, Ltd., Hitachi-High-Technologies Corporation. Active years: 2000-2011.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2000-2011
Title: Yoshiaki Igarashi: Innovator in Clinical Analysis Technology
Introduction
Yoshiaki Igarashi is a notable inventor based in Mito, Japan. He has made significant contributions to the field of clinical analysis technology, holding a total of 3 patents. His work focuses on improving the efficiency and effectiveness of clinical examinations through innovative inventions.
Latest Patents
Igarashi's latest patents include a reagent cassette and an automatic analyzer utilizing the same. This reagent cassette is designed for use in clinical examination rooms, allowing operators to select reagent bottles with appropriate capacities based on the number of tests required. It simplifies the process of setting reagents, enhancing the overall analysis environment. Additionally, he has developed a method for recovering multiple nucleic acids using an identical stationary phase. This invention captures nucleic components from various specimens without compromising the concentrations of nucleic acids, enabling the detection of specific components such as viruses.
Career Highlights
Throughout his career, Igarashi has worked with prominent companies, including Hitachi, Ltd. and Hitachi High-Technologies Corporation. His experience in these organizations has contributed to his expertise in clinical analysis and technology development.
Collaborations
Igarashi has collaborated with notable colleagues, including Mikio Komata and Tomonori Mimura. Their joint efforts have further advanced the innovations in the field of clinical analysis.
Conclusion
Yoshiaki Igarashi's contributions to clinical analysis technology through his patents and collaborations highlight his role as an influential inventor. His work continues to impact the efficiency of clinical examinations and the recovery of nucleic acids.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

